The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NSABP FR-2: Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer.
 
Thomas J. George
Consulting or Advisory Role - Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)
 
Greg Yothers
Employment - Mountainview Pediatrics (I); Mountainview Pediatrics (I); Mountainview Pediatrics (I); Mountainview Pediatrics (I)
Consulting or Advisory Role - Orbus Therapeutics; Orbus Therapeutics; Orbus Therapeutics; Orbus Therapeutics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics
 
Samuel A. Jacobs
No Relationships to Disclose
 
Gene Grant Finley
Speakers' Bureau - Astellas Medivation; Astellas Medivation; Astellas Medivation; Astellas Medivation; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Hiral D. Parekh
No Relationships to Disclose
 
Timothy David Moore
No Relationships to Disclose
 
Bassam Nabih Maalouf
Employment - Cancer Care Northwest; Cancer Care Northwest; Cancer Care Northwest; Cancer Care Northwest
 
John C. Krauss
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); ACCRU (Inst); ACCRU (Inst); ACCRU (Inst); ACCRU (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); Isofol Medical (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); OncoMed (Inst); Shire (Inst); Shire (Inst); Shire (Inst); Shire (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst)
 
Melvin Deutsch
No Relationships to Disclose
 
James J. Lee
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Incyte; Incyte; Incyte; Incyte; Loxo; Loxo; Loxo; Loxo
Research Funding - Merck; Merck; Merck; Merck
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Norman Wolmark
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst); NSABP Foundation (Inst)
Travel, Accommodations, Expenses - Genentech; Genentech; Genentech; Genentech